Development, Characterization and Application of Predictive-Toxicology Models

SAR and QSAR in Environmental Research

Volumn 10, Issue 2-3, 1999, Pages 277-298

  Rosenkranz, H S ^a   Cunningham, A R ^a   Zhang, Y P ^a   Claycamp, H G ^a   Macina, O T ^a   Sussman, N B ^a   Grant, S G ^a   Klopman, G ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

CASE MULTICASE; GLP; mechanism; metabolism; predictive toxicology; SAR; Toxicity

Indexed keywords

CASE/MULTICASE; CONTENT RATIO; EFFECT OF SIZES; GLP; MECHANISTICS; PREDICTIVE PERFORMANCE; PREDICTIVE TOXICOLOGY; PREDICTIVITY; RISKS ASSESSMENTS; SAR TECHNIQUES;

RISK ASSESSMENT;

ALGORITHM; ANIMAL; BIOLOGICAL MODEL; CHEMICAL MODEL; METHODOLOGY; PREDICTION AND FORECASTING; REVIEW; RISK ASSESSMENT; STRUCTURE ACTIVITY RELATION; TOXICOLOGY;

ALGORITHMS; ANIMALS; MODELS, BIOLOGICAL; MODELS, CHEMICAL; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; STRUCTURE-ACTIVITY RELATIONSHIP; TOXICOLOGY;

EID: 0032609573     PISSN: 1062936X     EISSN: 1029046X     Source Type: Journal    
DOI: 10.1080/10629369908039181     Document Type: Article

References (50)

1. Balls, M., Blaauboer, B., Brusick, D., Frazier, J., Lamb, D., Pemberton, M., Reinhardt, C., Roberfroid, M., Rosenkranz, H., Schmid, B., Speilmann, H., Stammati, A.-L., and Walum, E., 1990. Report and recommendations of the CAAT/ERGATT workshop on the validation of toxicity test procedures. ATLA, 18: 18–313.
2. Frierson, M. R., Klopman, G., and Rosenkranz, H. S., 1986. Structure-activity relationships among mutagens and carcinogens: A review. Environ. Mutagen., 8: 8–283.
3. Klopman, G., 1992. MULTICASE 1. A hierarchical computer automated structure evaluation program. Quant. Struct. Act. Rel., 11: 11–176.
4. Klopman, G., and Rosenkranz, H. S., 1984. Structural requirements for the mutagenicity of environmental nitroarenes. Mutation Res., 126: 126–227.
5. Klopman, G., and Rosenkranz, H. S., 1994. Prediction of carcinogenicity/mutagenicity using MULTICASE. Mutation Res., 305: 305–33.
6. Rosenkranz, H. S., Liu, M., Cunningham, A., and Klopman, G., 1996. Application of structural concepts to evaluate the potential carcinogenicity of natural products. SAR QSAR Env. Res., 5: 5–79.
7. Klopman, G., and Rosenkranz, H. S., 1995. Toxicity estimation by chemical substructure analysis: The Tox II program. Toxicol. Letters, 79: 79–145.
8. Rosenkranz, H. S., 1973. Aspects of microbiology in cancer research. Ann. Rev. Microbiol., 27: 27–383.
9. 1987. “IARC, Monographs on the Evaluation of Carcinogenic Risks to Humans: Genetic and Related Effects, Supplement 6.”. In Genetic and Related Effects., Lyon, France: International Agency for Research on Cancer.
10. Hollstein, M., and McCann, J., 1979. Short-term tests for carcinogens and mutagens. Mutation Res., 65: 65–133.
11. Upton, A. C., Clayson, D. G., Jansen, J. D., Rosenkranz, H. S., and Williams, G. M., 1984. Report of the international commission for protection against environmental mutagens and carcinogens task group on the differentiation between genotoxic and non-genotoxic carcinogens. Mutation Res., 133: 133–1.
12. Chankong, V., Haimes, Y. Y., Rosenkranz, H. S., and Pet-Edwards, J., 1985. The carcinogenicity prediction and battery selection (CPBS) method: A bayesian approach. Mutation Res., 153: 153–135.
13. Klopman, G., 1984. Artificial intelligence approach to structure-activity studies. Computer automated structure evaluation of biological activity of organic molecules. J. Amer. Chem. Soc., 106: 106–7315.
14. Cunningham, A. R., Klopman, G., and Rosenkranz, H. S., 1997. A dichotomy in the lipophilicity of natural estrogens/xenoestrogens and phytoestrogens. Environ. Health Perspect., 105: 105–665.
15. Pet-Edwards, J., Haimes, Y. Y., Chankong, V., Rosenkranz, H. S., and Ennever, F. K., 1989. “Risk Assessment and Decision Making Using Test Results: The Carcinogenicity Prediction and Battery Selection Approach.”. 221New York: Plenum Press.
16. Zhang, Y. P., Sussman, N., Macina, O. T., Rosenkranz, H. S., and Klopman, G., 1996. Prediction of the carcinogenicity of a second group of chemicals undergoing carcinogenicity testing. Environ. Health Perspect., 104: 104–1045.
17. Zhang, Y. P., Sussman, N., Klopman, G., and Rosenkranz, H. S., 1997. Development of methods to ascertain the predictivity and consistency of SAR models: Application to the U.S. National Toxicology Program rodent carcinogenicity bioassays. Quant. Struct.-Act. Relat., 16: 16–290.
18. Macina, O. T., Zhang, Y. P., and Rosenkranz, H. S., 1998. “Improved predictivity of chemical carcinogens: The use of a battery of SAR Models.”. In Carcinogenicity: Testing, Predicting and Interpreting Chemical Effects, Edited by: Kitchin, K. T., 227–260. New York: Marcel Dekker.
19. Rosenkranz, H. S., and Klopman, G., 1993. Structural evidence for a dichotomy in rodent carcinogenesis: Involvement of genetic and cellular toxicity. Mutation Res., 303: 303–83.
20. Rosenkranz, H. S., Zhang, Y. P., and Klopman, G., 1994. Evidence that cell toxicity may contribute to the genotoxic response. Regulatory Toxicol. Pharmacol., 19: 19–176.
21. Liu, M., Sussman, N., Klopman, G., and Rosenkranz, H. S., 1996. Structure-activity and mechanistic relationships: The effects of chemical overlap on structural overlap in data bases of varying size and composition. Mutation Res., 372: 372–79.
22. Liu, M., Sussman, N., Klopman, G., and Rosenkranz, H. S., 1996. Estimation of the optimal data base size for structure-activity analyses: The. Salmonella mutagenicity data base., Mutation Res., 358: 358–63.
23. Takihi, N., Zhang, Y. P., Klopman, G., and Rosenkranz, H. S., 1993. An approach for evaluating and increasing the informational content of mutagenicity and clastogenicity data bases. Mutagenesis, 8: 8–257.
24. Klopman, G., Dimayuga, M., and Talafous, J., 1994. META. 1. A program for the evaluation of metabolic transformation of chemicals. J. Chem. Inf. Comput. Sci., 34: 34–1320.
25. Talafous, J., Sayre, L. M., Mieyal, J. J., and Klopman, G., 1994. Meta. 2. A dictionary model of mammalian xenobiotic metabolism. J. Chem. Inf. Comput. Sci., 34: 34–1326.
26. Rosenkranz, H. S., Takihi, N., and Klopman, G., 1991. Structure activity-based predictive toxicology: An efficient and economical method for generating non-congeneric data bases. Mutagenesis, 6: 6–391.
27. Henry, B., Grant, S. G., Klopman, G., and Rosenkranz, H. S., 1998. Induction of forward mutations at the thymidine kinase locus of mouse lymphoma cells: Evidence for electrophilic and non-electrophilic mechanisms. Mutation Res., 397: 397–313.
28. Liu, M., Grant, S. G., Macina, O. T., Klopman, G., and Rosenkranz, H. S., 1997. Structural and mechanistic bases for the induction of mitotic chromosomal loss and duplication (“malsegregation”) in the yeast. Saccharomyces cerevisiae: Relevance to human carcinogenesis and developmental toxicity., Mutation Res., 374: 374–209.
29. Takihi, N., Rosenkranz, H. S., and Klopman, G., 1993. Identification of chemicals for testing in the rodent cancer bioassay. Quality Assurance: Good Practice, Regulation, and Law. 2: 232–243.
30. Takihi, N., Zhang, Y. P., Klopman, G., and Rosenkranz, H. S., 1993. An approach for evaluating and increasing the informational content of mutagenicity and clastogenicity data bases. Mutagenesis, 8: 8–257.
31. Yang, W.-L., Klopman, G., and Rosenkranz, H. S., 1992. Structural basis of the. in vivo micronuclei., Mutation Res., 272: 272–111.
32. Labbauf, A., Klopman, G., and Rosenkranz, H. S., 1997. Dichotomous relationship between DNA reactivity and the sister chromatid exchanges. in vivo and, in vitro. Mutation Res., 377: 377–37.
33. Ashby, J., and Tennant, R. W., 1991. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutation Res., 257: 257–229.
34. Gold, L. S., Manley, N. B., Slone, T. H., Garfinkel, G. B., Rohrbach, L., and Ames, B. N., 1993. The fifth plot of the Carcinogenic Potency Database: Results of animal bioassays published in the general literature through 1988, and by the National Toxicology Program through 1989. Environ. Health Perspect., 100: 100–65.
35. Gold, L. S., Sawyer, C. B., Magaw, R., Backman, G. M., deVeciana, M., Levinson, R., Hooper, N. K., Havender, W. R., Bernstein, L., Peto, R., Pike, M. C., and Ames, B. N., 1984. A carcinogenic potency database of the standardized results of animal bioassays. Environ. Health Perspect., 58: 58–9.
36. Spielmann, H., Liebsch, M., Kalweit, S., Moldenhauer, F., Wirnsberger, T., Holzhütter, H.-G., Schneider, B., Glaser, S., Gerner, I., Pape, W. J. W., Kreiling, R., Krauser, K., Miltenburger, H. G., Steiling, W., Luepke, N. P., Müller, N., Kreuzer, H., Mürmann, P., Spengler, J., Bertram-Neis, E., Siegemund, B., and Wieble, F. J., 1996. Results of a validation study in Germany on two. in vitro alternatives to the Draize eye irritation test, the HET-CAM test and the 3T3 NRU cytotoxicity test., ATLA, 24: 24–741.
37. Lee, Y., Rosenkranz, H. S., Buchanan, B. G., Mattison, D. R., and Klopman, G., 1995. Learning rules to predict rodent carcinogenicity of non-genotoxic chemicals. Mutation Res., 328: 328–127.
38. Lee, Y., Buchanan, B. G., Klopman, G., Dimayuga, M., and Rosenkranz, H. S., 1996. The potential of organ specific toxicity for predicting rodent carcinogenicity. Mutation Res., 358: 358–37.
39. Mersch-Sundermann, V., Klopman, G., and Rosenkranz, H. S., 1996. Chemical structure and genotoxicity: Studies of the SOS chromotest. Mutation Res., 340: 340–81.
40. Rosenkranz, H. S., Cunningham, A., and Klopman, G., 1996. Identification of a 2-D geometric descriptor associated with non-genotoxic carcinogens and some estrogens and antiestrogens. Mutagenesis, 11: 11–95.
41. Cunningham, A. R., Rosenkranz, H. S., and Klopman, G., 1998. Structural analysis of a group of phytoestrogens for the presence of a 2-D geometric descriptor associated with non-genotoxic carcinogens and some estrogens. Proc. Soc. Expt. Biol. Med., 217: 217–288.
42. Tinwell, H., and Ashby, J., 1994. Genetic toxicity and potential carcinogenicity of taxol. Carcinogenesis, 15: 15–1499.
43. Long, B. H., 1995. Paclitaxel induces the formation of micronuclei and cytotoxicity in human carcinoma cells and mouse fibroblasts in culture, independent of its ability to arrest cells in mitosis. Proc. Amer. Assoc. Cancer Res., 36: 455
44. Ashby, J., and Morrod, R. S., 1991. Detection of human carcinogens. Nature, 352: 352–185.
45. Zhang, Y. P., Macina, O. T., Rosenkranz, H. S., Karol, M. H., Mattison, D. R., and Klopman, G., 1997. Prediction of the metabolism and toxicological profiles of oxygenates added to gasoline. Inhalation Toxicol., 9: 9–237.
46. Cunningham, A. R., Rosenkranz, H. S., Zhang, Y. P., and Klopman, G., 1998. Identification of “genotoxic” and “non-genotoxic” alerts for cancer in mice: The carcinogenicity potency data base. Mutation Res., 398: 398–1.
47. Cunningham, A. R., Klopman, G., and Rosenkranz, H. S., 1998. Identification of structural features and associated mechanisms of action for carcinogens in rats. Mutation Res., 405: 405–9.
48. Rosenkranz, H. S., and Klopman, G., 1990. Structural basis of carcinogenicity in rodents of genotoxicants and non-genotoxicants. Mutation Res., 228: 228–105.
49. Ter Haar, E., Day, B. W., and Rosenkranz, H. S., 1996. Direct tubulin polymerization perturbation contributes significantly to the induction of micronuclei. in vivo. Mutation Res., 350: 350–331.
50. Ter Haar, E., Rosenkranz, H. S., Hamel, E., and Day, B. W., 1996. Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents. Bioorganic Med. Chem., 4: 4–659.